 | Sarepta Therapeutics, Inc. | |||
| NMS : SRPT || Location: United States | ||||
$118.31-4.56 (-3.71%) |
0.86 M | 117.78 - 122.99 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 4.597 M |
| March 15, 2024 | 4.967 M |
| Feb. 29, 2024 | 4.781 M |
| Feb. 15, 2024 | 4.806 M |
| Jan. 31, 2024 | 5.171 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 0.02 | 0.47 | 3012.58% |
| 09/30/2023 | -1.26 | -0.46 | 63.36% |
| 06/30/2023 | -1.81 | -0.27 | 85.10% |
| 03/31/2023 | -1.41 | -5.86 | -315.34% |
| 12/31/2022 | -1.37 | -1.24 | 9.79% |
SRPT Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 93.855M | Shares Float | 89.606M |
| Short Float | 4.597M | Market Cap | 11103.99M |
| Institution ownership | 87.92% | Insider ownership | 4.302% |
| Earnings Date | 05/01/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -5.80 | Forward EPS | 11.04 |